Patients devastated by HSE decision not to fund treatment for rare genetic disease

Patients suffering from a rare genetic disease say they are devastated that the HSE has decided not to fund a new treatment for the condition.

Patients devastated by HSE decision not to fund treatment for rare genetic disease

Patients suffering from a rare genetic disease say they are devastated that the HSE has decided not to fund a new treatment for the condition.

The decision affects 60 patients who suffer from Alpha 1 - a genetic form of Emphysema.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited